non-small cell lung cancer News
Most Popular non-small cell lung cancer Story
Positive results for AstraZeneca's lung cancer drug
According to Phase II results published in the Journal of Clinical Oncology, AstraZeneca's drug vandetanib (Zactima) improved progression free survival in patients with advanced lung cancer.... Read more...
Latest Headlines
- September 21, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
